Clinical Trial Applications: Filter, Search, and view applications


Clear
Extended search...

Page 12 of 21, showing 5 Applications out of 104 total, starting on record 56, ending on 60

# Protocol No Study Title Investigator(s) & Site(s)

56.

ECCT/18/04/02   Maternal Influenza Vaccine Study
    Impact of HIV Infection and Malaria Parasitemia on Immunogenicity of Inactivated Influenza Vaccine in Pregnant Women and on Mother-to-Child Vaccine-induced Antibody Transfer   
Principal Investigator(s)
1. Sandra S Chaves
Site(s) in Kenya
1. Siaya County Referral Hospital (Siaya county)
2. Bondo Sub-County Hospital (Siaya county)
 
View

57.

ECCT/18/03/01   JiPime JiPrEP (HIVST Study)
    HIV self-testing to improve the efficiency of PrEP delivery.   
Principal Investigator(s)
1. Kenneth Kairu Ngure
Site(s) in Kenya
KEMRI-CCR PHRD (THIKA)
 
View

58.

ECCT/17/08/06   Enhancing Preventive Therapy of Malaria In children with Sickle cell anemia in East Africa (EPiTOMISE)
    Enhancing Preventive Therapy of Malaria In children with Sickle cell anemia in East Africa (EPiTOMISE)   
Principal Investigator(s)
1. Festus Muigai Njuguna
Site(s) in Kenya
Homa Bay County Hospital
 
View

59.

ECCT/17/08/04   P1081
    A PHASE IV RANDOMIZED TRIAL TO EVALUATE THE VIROLOGIC RESPONSE AND PHARMACOKINETICS OF TWO DIFFERENT POTENT REGIMENS IN HIV INFECTED WOMEN INITIATING TRIPLE ANTIRETROVIRAL REGIMENS BETWEEN 28 AND 36 WEEKS OF PREGNANCY FOR THE PREVENTION OF MOTHER-TO-CHILD TRANSMISSION:    NICHD P1081   
Principal Investigator(s)
1. FREDRICK KIPYEGON SAWE
Site(s) in Kenya
Kenya Medical Research Institute Walter Reed Project Clinical Research Centre.
 
View

60.

ECCT/17/08/01   A trial to compare the safety and immune response of the normal full and reduced doses of yellow fever vaccines in Kenyan adults
    A Phase IV randomized, double blinded non-inferiority trial on the immunogenicity and safety of fractional doses of yellow fever vaccines.   
Principal Investigator(s)
1. Philip Bejon
Site(s) in Kenya
KEMRI Kilifi
 
View